Patents by Inventor Eduardo Antonio Ferraz Coelho

Eduardo Antonio Ferraz Coelho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (RPE)
    Patent number: 8969019
    Abstract: The invention relates to a diagnosis method for Leishmaniasis using a RPE.
    Type: Grant
    Filed: July 13, 2010
    Date of Patent: March 3, 2015
    Assignee: Laboratorios Leti, S.L.
    Inventors: Manuel Soto-Álvarez, Laura Ramírez-García, Eduardo Antonio Ferraz Coelho, Carlos Alonso-Bedate
  • Vaccine composition and immunization method
    Patent number: 8968749
    Abstract: The present invention refers to the recombinant vaccine against canine visceral leishmaniasis containing the recombinant A2 protein and saponin, monophosphoryl lipid A, or aluminum hydroxide plus CpG as an adjuvant, allowing the distinction between vaccinated and infected animals through conventional ELISA or immunofluorescence tests that employ antigens of promastigote forms of Leishmania.
    Type: Grant
    Filed: May 27, 2014
    Date of Patent: March 3, 2015
    Assignee: Universidade Federal de Minas Gerais—UFMG
    Inventors: Ana Paula Salles Moura Fernandes, Christiane De Freitas Abrantes, Eduardo Antonio Ferraz Coelho, Ricardo Tostes Gazzinelli
  • VACCINE COMPOSITION AND IMMUNIZATION METHOD
    Publication number: 20140255448
    Abstract: The present invention refers to the recombinant vaccine against canine visceral leishmaniasis containing the recombinant A2 protein and saponin, monophosphoryl lipid A, or aluminum hydroxide plus CpG as an adjuvant, allowing the distinction between vaccinated and infected animals through conventional ELISA or immunofluorescence tests that employ antigens of promastigote forms of Leishmania.
    Type: Application
    Filed: May 27, 2014
    Publication date: September 11, 2014
    Inventors: Ana Paula Salles Moura FERNANDES, Christiane De Freitas Abrantes, Eduardo Antonio Ferraz Coelho, Ricardo Tostes Gazzinelli
  • Vaccine composition and immunization method
    Patent number: 8734815
    Abstract: The present invention refers to the recombinant vaccine against canine visceral leishmaniasis containing the recombinant A2 protein and saponin, as an adjuvant, allowing the distinction between vaccinated and infected animals through conventional ELISA or immunofluorescence tests that employ antigens of promastigote forms of Lesihmania.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: May 27, 2014
    Assignee: Universidade Federal de Minas Gerais
    Inventors: Ana Paula Salles Moura Fernandes, Christiane De Freitas Abrantes, Eduardo Antonio Ferraz Coelho, Ricardo Tostes Gazzinelli
  • LEISHMANICIDAL FORMULATION AND ITS USE
    Publication number: 20130142819
    Abstract: The present invention refers to pharmaceutical formulations obtained from the aqueous extract of the fungus Agaricus blazei and its purified fractions for the treatment of leishmaniasis. More particularly, the present invention discloses formulations preferably for topic and oral use, in form of solid, semi-solid and liquid pharmaceutical formulations selected from a group consisting of gel, cream, ointment, pastes, emulsions in general, solutions, tablets and capsules for the treatment of canine and human cutaneous and visceral leishmaniasis.
    Type: Application
    Filed: May 11, 2011
    Publication date: June 6, 2013
    Inventors: Eduardo Antonio Ferraz Coelho, Wiliam César Bento Régis, Diogo Garcia Valadares, Carlos Alberto Pereira Tavares, Ana Paula Salles Moura Fernandes, Jamil Silvano De Oliveira, Marcelo Matos Santoro
  • DIAGNOSIS OF A PARASITIC DISEASE SUCH AS LEISHMANIASIS USING RIBOSOMAL PROTEIN EXTRACT (RPE)
    Publication number: 20120178109
    Abstract: The invention relates to a diagnosis method for Leishmaniasis using a RPE.
    Type: Application
    Filed: July 13, 2010
    Publication date: July 12, 2012
    Inventors: Manuel Soto-Álvarez, Laura Ramírez-García, Eduardo Antonio Ferraz Coelho, Carlos Alonso-Bedate
  • VACCINE COMPOSITION AND IMMUNIZATION METHOD
    Publication number: 20110008391
    Abstract: The present invention refers to the recombinant vaccine against canine visceral leishmaniasis containing the recombinant A2 protein and saponin, as an adjuvant, allowing the distinction between vaccinated and infected animals through conventional ELISA or immunofluorescence tests that employ antigens of promastigote forms of Leishmania.
    Type: Application
    Filed: July 20, 2007
    Publication date: January 13, 2011
    Applicant: FEDERAL UNIVERSITY OF MINAS GERAIS - UFMG
    Inventors: Ana Paula Salles Moura Fernandes, Christiane De Freitas Abrantes, Eduardo Antonio Ferraz Coelho, Ricardo Tostes Gazzinelli